FDA 483 - LEC Custom Products, Inc - September 02, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
LEC Custom Products, Inc., an OTC drug manufacturer in Mississauga, Ontario, was cited for significant deficiencies across its quality control, production, and labeling operations. The inspection revealed inadequate master production records, failures in deviation management, and issues with equipment qualification and cleaning. Additionally, the firm lacked proper control over labeling and equipment traceability, indicating systemic weaknesses in maintaining cGMP compliance.
ID · 3703f854-0bf3-4aea-b8e2-6e6d428860a9